| Trial ID: | L0004 |
| Source ID: | NCT02381275
|
| Associated Drug: |
Tenofovir Disoproxil Fumarate
|
| Title: |
The Lighthouse Tenofovir Cohort Study
|
| Acronym: |
LighTen
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Disease
|
| Interventions: |
DRUG: Tenofovir Disoproxil Fumarate
|
| Outcome Measures: |
Primary: Proportion of HIV-infected individuals with renal dysfunction, Patients will be followed in the clinic up to 36 months, 36 months post ART initiation | Secondary: Proportion of HIV-infected individuals with HIV/ HBV and HCV infections, Patients will be followed in the clinic up to 36 months, 36 months post ART initiation
|
| Sponsor/Collaborators: |
Sponsor: Lighthouse Trust | Collaborators: Heidelberg University|Ministry of Health, Malawi|University of Cologne
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
1500
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2014-08-14
|
| Completion Date: |
2018-07
|
| Results First Posted: |
|
| Last Update Posted: |
2018-06-07
|
| Locations: |
Lighthouse Clinic, Lilongwe, 0000, Malawi
|
| URL: |
https://clinicaltrials.gov/show/NCT02381275
|
